Vrancken Kristof, Anné Jozef
Rega Institute, Laboratory of Bacteriology, KU Leuven, Minderbroedersstraat 10, Leuven, B-3000, Belgium.
Future Microbiol. 2009 Mar;4(2):181-8. doi: 10.2217/17460913.4.2.181.
Bacterial systems are widely applied as production platforms for proteins of biopharmaceutical or therapeutic interest and industrial enzymes. Among these prokaryotic systems, streptomycetes are attractive host cells because several strains of these Gram-positive bacteria have a high innate secretion capacity and extensive knowledge on their fermentation is available. A survey of the literature and our own experience suggests that several proteins are secreted to commercially acceptable levels. However, many heterologous proteins, most often of eukaryotic origin, are currently only poorly secreted by this host, indicating the need for further optimization of Streptomyces as a production host. In this review, the considerable efforts and strategies made in recent years aimed at improving streptomycetes as a host for the production of recombinant proteins will be discussed.
细菌系统被广泛用作生产具有生物制药或治疗意义的蛋白质以及工业酶的平台。在这些原核系统中,链霉菌是有吸引力的宿主细胞,因为这些革兰氏阳性细菌的几个菌株具有较高的天然分泌能力,并且关于它们发酵的知识也很丰富。对文献的调查和我们自己的经验表明,几种蛋白质的分泌水平达到了商业可接受的程度。然而,目前许多异源蛋白质,大多数是真核起源的,在这个宿主中分泌得很差,这表明需要进一步优化链霉菌作为生产宿主。在这篇综述中,将讨论近年来为改进链霉菌作为重组蛋白生产宿主所做的大量努力和策略。